Recursion Pharmaceuticals, Inc. Class A Common Stock

Go to Recursion Pharmaceuticals, Inc. Class A Common Stock Website

$5.62

-0.33 (-5.55%)
Live
Previous Close

$5.68

Day Range

$5.575 - $5.82

Previous Day Range

$5.785 - $6.09

Market Cap

$2.5 billion USD

Day Vol.

18.0 million

Previous Day Vol.

22.0 million

Currency

USD

Primary Exchange

Nasdaq

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improvi...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

The article explores two promising biotech companies, Viking Therapeutics and Recursion Pharmaceuticals, highlighting their innovative approaches in weight loss treatments and AI-driven drug development, respectively.

Related tickers: VKTX, RXRX, SMMT, ABVX.

Read Full Article

The global drug discovery platforms market is projected to grow from $186.24 million in 2024 to $635.45 million by 2034, driven by AI, technological advancements, and increased pharmaceutical R&D investments. North America leads the market, with Asia-Pacific expected to see the fastest growth.

Related tickers: EVO, PFE, MRK, RXRX.

Read Full Article
Trending Tickers

Please sign in to view